The therapy has been available in France by prescription since 2024, but has not been approved for reimbursement by the national health insurance system until now
Every agent in this therapeutic story native GLP-1, the injectable peptide analogs, oral semaglutide, and orforglipron ultimately does its work by turning on this one receptor and thereby recruiting the glucose-lowering and weight-reducing physiology that incretin signaling produces
J Diabetes 7:584588 [DOI] [PubMed] [Google Scholar] 67.Wen B, Zhao L, Zhao H, Wang X (2018) Liraglutide exerts a bone-protective effect in ovariectomized rats with streptozotocin-induced diabetes by inhibiting osteoclastogenesis
Wegovy belongs to a group of medicines called GLP-1 receptor agonists
Specifications: Unit Size: 50mg/100mg (vial format) Purity: 99% (HPLC verified) Form: Lyophilized powder CAS Number: 89030-95-5 Molecular Formula: CHCuNO Sequence: Gly-His-LysCu Storage: Keep in a cool, dry environment
Koytchev R, Alken RG, Dundarov S